Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jan;41(1):254-60.
doi: 10.1128/JCM.41.1.254-260.2003.

Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay

Affiliations

Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay

Patrice Francois et al. J Clin Microbiol. 2003 Jan.

Abstract

A rapid procedure was developed for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) directly from sterile sites or mixed flora samples (e.g., nose or inguinal swabs). After a rapid conditioning of samples, the method consists of two main steps: (i) immunomagnetic enrichment in S. aureus and (ii) amplification-detection profile on DNA extracts using multiplex quantitative PCR (5'-exonuclease qPCR, TaqMan). The triplex qPCR assay measures simultaneously the following targets: (i) mecA gene, conferring methicillin resistance, common to both S. aureus and Staphylococcus epidermidis; (ii) femA gene from S. aureus; and (iii) femA gene from S. epidermidis. This quantitative approach allows discrimination of the origin of the measured mecA signal. qPCR data were calibrated using two reference strains (MRSA and methicillin-resistant S. epidermidis) processed in parallel to clinical samples. This 96-well format assay allowed analysis of 30 swab samples per run and detection of the presence of MRSA with exquisite sensitivity compared to optimal culture-based techniques. The complete protocol may provide results in less than 6 h (while standard procedure needs 2 to 3 days), thus allowing prompt and cost-effective implementation of contact precautions.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Effect of antibody concentration on S. aureus recovery rate. Cowan I strain (NCTC8530; 103 CFU) was used to evaluate the optimal concentration of anti-spa antibodies required for the enrichment step. (A) Recovery was determined by CFU counts of immunocaptured colonies. The curve showed maximal recovery at an antibody dilution of 1:666. (B). Using this optimized anti-spa dilution, recovery was assessed across >7 orders of magnitude in inoculum size. Average values ± standard errors of the means for four experiments performed in duplicate are given.
FIG. 2.
FIG. 2.
Immunocapture of MRSA from mixed cultures. 5 (A), 60 (B), or 1,000 (C) CFU of MRSA (ATCC 33591) was mixed with increasing titers of MRSE, yielding ratios ranging from 1:1 to 1:1,000 for S. aureus (black bars) versus S. epidermidis (grey bars). Immunocapture was evaluated by viable CFU counts performed on MH agar. Means ± ranges for two experiments performed in duplicate are shown. ∗, <10 CFU of MRSE.
FIG. 3.
FIG. 3.
Linearity and limits of detection of the qPCR assay. The linear response of the qPCR mecA assay as a function of input genomic DNA (2 fg to 10 ng) purified from strain ATCC33591 is shown. Correlation coefficient, >0.99; slope, −3.59. Values are means ± standard errors of the means of 4 to 16 determinations. ∗, value excluded from linear regression. ∗∗, amounts of input DNA leading to irregular signal detection.
FIG. 4.
FIG. 4.
Effect of the immunocapture procedure on the qPCR assay. S. aureus (ATCC 33591; 103 CFU) was mixed with various S. epidermidis titers (MRSE) and analyzed by qPCR following (○) or not following (•) immunocapture enrichment. MRSA in the presence of >100-fold-excess amounts of MRSE was not detected (NA). Values are means ± standard errors of the means for three experiments performed in triplicate.

References

    1. Abramson, M. A., and D. J. Sexton. 1999. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect. Control Hosp. Epidemiol. 20:408-411. - PubMed
    1. Alborn, W. E., Jr., J. Hoskins, S. Unal, J. E. Flokowitsch, C. A. Hayes, J. E. Dotzlaf, W. K. Yeh, and P. L. Skatrud. 1996. Cloning and characterization of femA and femB from Staphylococcus epidermidis. Gene 180:177-181. - PubMed
    1. Berger-Bachi, B., L. Barberis-Maino, A. Strassle, and F. H. Kayser. 1989. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol. Gen. Genet. 219:263-269. - PubMed
    1. Boyce, J. M. 2001. MRSA patients: proven methods to treat colonization and infection. J. Hosp. Infect. 48(Suppl. A):S9-S14. - PubMed
    1. Cavassini, M., A. Wenger, K. Jaton, D. S. Blanc, and J. Bille. 1999. Evaluation of MRSA-Screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus. J. Clin. Microbiol. 37:1591-1594. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources